Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Aug 8:17:1937-1945.
doi: 10.2147/RMHP.S468700. eCollection 2024.

Factors Influencing the Use and Demand of New Coronavirus Therapy Drugs Among the Adults During COVID-19 in China

Cunchuan Chen #  1   2 , Huifang Zhang #  1   2 , Xia Feng  1   2 , Haipeng Wang  1   2
Affiliations

Factors Influencing the Use and Demand of New Coronavirus Therapy Drugs Among the Adults During COVID-19 in China

Cunchuan Chen et al. Risk Manag Healthc Policy. .

Abstract

Background: This alteration in the policy of COVID-19 resulted in widespread infections throughout China. Most people only need some antiviral drugs such as lopinavir/ritonavir or Chinese herbal preparations for treatment. In this context, the lack of drug knowledge and inadequate drug availability are evident. This study aims to explore the factors influencing drug use and demand during the COVID-19 epidemic.

Methods: This study used quota sampling based on gender, age, and place of residence to perform a cross-sectional survey on a sample of 771 adults. The researchers used chi-square tests to understand differences in drug use and demand across characteristics, and binary logistic regression to analyse the influencing factors.

Results: The study revealed that 85.9% of the participants used drugs following the COVID-19 infection. Participants with college and above, (OR=2.49, 95% CI=1.27-4.88) annual personal income between 30,000 and 80,000CNY (OR=2.19, 95% CI=1.35-3.55) and over 80,000CNY (OR=1.96, 95% CI=1.05-3.66) were more knowledgeable about using drugs. Gender, (OR=0.69, 95% CI=0.50-0.95) age, (OR=2.11, 95% CI=1.15-3.88) residence, (OR=1.58, 95% CI=1.06-2.37) chronic disease conditions (OR=0.46, 95% CI=0.27-0.78) and infection symptoms (OR=0.60, 95% CI=0.38-0.93) as factors influencing the need for drug delivery services. (P<0.05).

Conclusion: Research has revealed that a significant proportion of infected people in China chose drug treatment during COVID-19. Individuals with severe symptoms use more medication and require more drug delivery and storage. Low-education and low-income populations are lacking in drug knowledge, and older adults with underlying medical conditions are more likely to need drug delivery services. Therefore, governments should prioritize vulnerable groups when formulating drug policies and target drug literacy and guidance. In addition, it is recommended that a drug distribution system be set up within the community so that those in need can have quick and easy access to drugs.

Keywords: COVID-19; drug delivery; drug demand; drug stockpiling; drug use.

PubMed Disclaimer

Conflict of interest statement

The authors declared no potential conflicts of interest concerning the research, authorship, and/or publication of this article.

References

    1. Lu H, Stratton CW, Tang YW. Outbreak of pneumonia of unknown etiology in Wuhan, China: the mystery and the miracle. J Med Virol. 2020;92(4):401–402. doi:10.1002/jmv.25678 - DOI - PMC - PubMed
    1. Hui DS, Azhar EI, Madani TA, et al. The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health - The latest 2019 novel coronavirus outbreak in Wuhan, China. Int J Infect Dis. 2020;91:264–266. doi:10.1016/j.ijid.2020.01.009 - DOI - PMC - PubMed
    1. Dabestani A, DeAngelo D, Chhay SR, Larson BJ, Ganio MC. Medication utilization in patients in New York hospitals during the COVID-19 pandemic. Am J Health Syst Pharm. 2020;77(22):1885–1892. doi:10.1093/ajhp/zxaa251 - DOI - PMC - PubMed
    1. Phelan AL, Katz R, Gostin LO. The Novel Coronavirus Originating in Wuhan, China: challenges for Global Health Governance. JAMA. 2020;323(8):709–710. doi:10.1001/jama.2020.1097 - DOI - PubMed
    1. The Lancet. China’s response to COVID-19: a chance for collaboration. Lancet. 2021;397(10282):1325. doi:10.1016/S0140-6736(21)00823-0 - DOI - PMC - PubMed

LinkOut - more resources